SANUWAVE Health, Inc. (SNWV)
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
SANUWAVE Health, Inc.
Trials need funding. See this company's dilution risk and cash position.
- Phase 3Completed
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
acoustical pulse energy (extracorporeal shockwave), Sham
Diabetic Foot Ulcers
NCT00536744Enrollment206StartOct 2007Primary CompletionJun 2010CompletionSep 2010 - Phase 3Unknown status
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
Electrohydraulic-generated shock wave, Sham device plus standard of care
Diabetic Foot Ulcers
NCT01824407Enrollment90StartMar 2013Primary CompletionApr 2014est.Completion- - Not applicableTerminated
The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs
dermaPACE
Diabetic Foot Ulcer
NCT03640988Enrollment2StartApr 2019Primary CompletionJan 2021CompletionJan 2021
| Drug / Therapy | Link | ||
|---|---|---|---|
| Phase 3 | Completed | acoustical pulse energy (extracorporeal shockwave), Sham | NCT00536744 |
| Phase 3 | Unknown status | Electrohydraulic-generated shock wave, Sham device plus standard of care | NCT01824407 |
| Not applicable | Terminated | dermaPACE | NCT03640988 |